Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PMM2 | O15305 | 1/20 | 0.34 |
| ▸ | MPI | P34949 | 1/20 | 0.34 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17367040 | 0.86 | KDM4E (0.39) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL17367107 | 0.86 | KDM4E (0.41) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL15073715 | 0.84 | KDM4E (0.49) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL17451664 | 0.84 | KDM4E (0.47) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL10014542 | 0.83 | PMM2 (0.40) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL23204243 | 0.83 | KDM4E (0.49) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL23233714 | 0.83 | KDM4E (0.49) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL15126698 | 0.82 | PMM2 (0.35) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL17367127 | 0.82 | PMM2 (0.38) | KDM4EATML3MBTL1PMM2MPI | |
| SCHEMBL18868249 | 0.82 | KDM4E (0.38) | KDM4EATML3MBTL1PMM2MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, CRY1, CYP1B1 | KDM4E 3404/4885ATM 3202/4885L3MBTL1 717/4885 |
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | CYP1A1, CRY1, CYP1B1 | KDM4E 3404/4885ATM 3202/4885L3MBTL1 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.